hydantoins has been researched along with Neuralgia in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angeli, A; Bartolucci, G; Carta, F; Di Cesare Mannelli, L; Ghelardini, C; Menicatti, M; Peat, TS; Supuran, CT | 1 |
| Cho, JH; Hien, TT; Kang, KW; Kim, S; Kim, YC; Kim, YG; Ko, H; Lee, GE; Lee, SD; Lim, SC; Park, JH; Yang, JW | 1 |
| Baker, J; Boyce, S; Broeders-Josten, S; Cals, J; Cottney, J; de Kimpe, V; de Roos, J; Hermkens, M; King, A; Klomp, J; Oosterom, J; Pols-de Rooij, I; van der Doelen, AA; van der Stelt, M; van Tilborg, M | 1 |
| LEMOYNE, J | 1 |
| Mehmke, S | 1 |
| Lützenkirchen, H; Mertens, HG | 1 |
8 other study(ies) available for hydantoins and Neuralgia
| Article | Year |
|---|---|
Benzensulfonamides bearing spyrohydantoin moieties act as potent inhibitors of human carbonic anhydrases II and VII and show neuropathic pain attenuating effects.
Topics: Analgesics; Animals; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Crystallography, X-Ray; Drug Design; Humans; Hydantoins; Male; Mice; Molecular Structure; Neuralgia; Structure-Activity Relationship; Sulfonamides | 2019 |
Discovery of novel 2,5-dioxoimidazolidine-based P2X(7) receptor antagonists as constrained analogues of KN62.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Arthritis, Experimental; Carrageenan; Cattle; Collagen Type II; Drug Discovery; Edema; Enzyme-Linked Immunosorbent Assay; HEK293 Cells; Humans; Hydantoins; Immunoblotting; Inflammation; Interleukin-1beta; Long-Term Potentiation; Macrophages; Male; Mice, Inbred DBA; Molecular Structure; Monocytes; Neuralgia; Purinergic P2X Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2X7; Structure-Activity Relationship; Sulfonic Acids; Tissue Distribution | 2015 |
Discovery and optimization of 1-(4-(pyridin-2-yl)benzyl)imidazolidine-2,4-dione derivatives as a novel class of selective cannabinoid CB2 receptor agonists.
Topics: Administration, Oral; Analgesics; Animals; Caco-2 Cells; Cell Membrane Permeability; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Cyclic S-Oxides; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; HEK293 Cells; Humans; Hydantoins; In Vitro Techniques; Male; Microsomes, Liver; Neuralgia; Rats; Rats, Wistar; Receptor, Cannabinoid, CB2; Spinal Nerves; Structure-Activity Relationship | 2011 |
[Essential facial neuralgia therapy with dimethyl-dithio-hydantoin].
Topics: Anticonvulsants; Facial Neuralgia; Hydantoins; Imidazoles; Neuralgia; Trigeminal Neuralgia | 1951 |
[Dimethyl-dithio-hydantoin therapy in essential facial neuralgia].
Topics: Anticonvulsants; Face; Facial Neuralgia; Hydantoins; Imidazoles; Neuralgia | 1951 |
[Facial neuralgia therapy by hydantoin derivatives].
Topics: Anticonvulsants; Facial Nerve; Facial Neuralgia; Humans; Hydantoins; Neuralgia | 1951 |
[Therapy of glossopharyngeal neuralgia].
Topics: Analgesics; Anesthetics, Local; Barbiturates; Denervation; Glossopharyngeal Nerve; Humans; Hydantoins; Hypnotics and Sedatives; Neuralgia; Pain; Phenothiazines; Phytotherapy; Plants, Medicinal; Rauwolfia | 1969 |
[Neuropsychotropic drugs in the treatment of so-called pain syndromes].
Topics: Aminobutyrates; Benperidol; Chronic Disease; Diazepam; Humans; Hydantoins; Neuralgia; Pain; Procainamide; Psychopharmacology; Tranquilizing Agents | 1970 |